Review
[Resistance against tyrosine kinase inhibitors in the treatment of GIST. New therapeutic possibilities appear]
[Article in
Swedish]
Affiliations
- PMID: 20180446
Item in Clipboard
Review
[Resistance against tyrosine kinase inhibitors in the treatment of GIST. New therapeutic possibilities appear]
[Article in
Swedish]
Lakartidningen.
2009 Dec.
No abstract available
Similar articles
-
[Responses to treatment and switching tyrosine kinase inhibitors in gastrointestinal stromal tumor(GIST)].Gan To Kagaku Ryoho. 2012 Sep;39(9):1330-5. Gan To Kagaku Ryoho. 2012. PMID: 22996768 Japanese.
-
[Consensus on the medical treatment of gastrointestinal stromal tumors].Zhonghua Zhong Liu Za Zhi. 2007 Nov;29(11):875-7. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18396652 Chinese. No abstract available.
-
Hits and misses in targeting pediatric cancers.Pediatr Blood Cancer. 2009 Jul;52(7):751-2. doi: 10.1002/pbc.21937. Pediatr Blood Cancer. 2009. PMID: 19185009 No abstract available.
-
Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib.Ann Oncol. 2012 Jul;23(7):1680-7. doi: 10.1093/annonc/mdr598. Epub 2012 Feb 21. Ann Oncol. 2012. PMID: 22357255 Clinical Trial.
-
A decade of tyrosine kinase inhibitor therapy: Historical and current perspectives on targeted therapy for GIST.Cancer Treat Rev. 2011 Aug;37(5):373-84. doi: 10.1016/j.ctrv.2010.11.003. Epub 2010 Dec 30. Cancer Treat Rev. 2011. PMID: 21195552 Review.